Skip to main content

Closed

PCVX: Vaxcyte, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-35.0%

Financially safe

Stretched

Debt / equity0.04×

Interest coverage0.0×

Current ratio7.49×

Vaxcyte, Inc.

PCVXNASDAQ Global Select·USD·Closed

Vaxcyte, Inc.

PCVXNASDAQ·USD·Closed

$54.08

−3.36%

$54.08

−$1.88 (3.36%)

52W Range

70thpctl

Volume

0.46×avg

Mkt Cap

7.81BUSD

P/E

-7.8TTM

Div Yield

–ann

52W Range

70thpctl

Volume

0.46×avg

Market Cap

7.81BUSD

P/E Ratio

-7.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings